[Treatment of cytomegalovirus infections in allogeneic bone marrow transplantation]

[Article in French]

Affiliations

Review

[Article in French]

A Devergie et al. Rev Fr Transfus Hemobiol. 1991 Oct.

. 1991 Oct;34(5):395-402.

doi: 10.1016/s1140-4639(05)80215-1.

No abstract available

Similar articles

Prophylaxis of cytomegalovirus infection after bone marrow transplantation.
Schmidt GM. Schmidt GM. Semin Oncol. 1992 Jun;19(3 Suppl 7):20-6. Semin Oncol. 1992. PMID: 1319612 Review.
Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation.
Devergie A, Traineau R, Esperou-Bourdeau H, Ribaud P, Socié G, Richard P, Selimi F, Hirsch I, Gluckman E. Devergie A, et al. Nouv Rev Fr Hematol (1978). 1994;36 Suppl 1:S89-90. Nouv Rev Fr Hematol (1978). 1994. PMID: 8177726
Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.
Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, Riddell SR. Walter EA, et al. N Engl J Med. 1995 Oct 19;333(16):1038-44. doi: 10.1056/NEJM199510193331603. N Engl J Med. 1995. PMID: 7675046 Clinical Trial.
Current approaches to the prevention and treatment of cytomegalovirus disease after bone marrow transplantation: an overview.
Levin MJ. Levin MJ. Semin Hematol. 1990 Apr;27(2 Suppl 1):1-4; discussion 28-9. Semin Hematol. 1990. PMID: 2160125 Review. No abstract available.
Ganciclovir and the prevention of CMV disease after allogeneic BMT: policy at the Hammersmith Hospital.
Ward KN, Roberts IA, van Rhee F. Ward KN, et al. Bone Marrow Transplant. 1994 Feb;13(2):230-1. Bone Marrow Transplant. 1994. PMID: 8205098 No abstract available.